Events
Space shortcuts
Space Tools
Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 9 Next »

Session Summary

The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.

 

Presenter (4)
Presentations

Douglas MacFadden

Chief Informatics Officer

Harvard Catalyst

P1: SHRINE Update
  • Review of all the new features added to the SHRINE Software

 


 


 

Nich Wattanasin, MS

Corporate Team Lead

Partners HealthCare

 

 

P2: Feasibility Studies Using SHRINE and i2b2
  • New features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials.

 

 


 


 

 

Jack London, MD

 

P3: 

 


 

 

Kavi Wagholikar, PhD

 

Assistant in Computer Science

Massachusetts General Hospital

P4: SMART on FHIR on i2b2
  • Review of new FHIR cell
  • Standardizing docker containers

 

  • No labels